MX2019001257A - Celulas renales bioactivas para el tratamiento de enfermedad renal cronica. - Google Patents

Celulas renales bioactivas para el tratamiento de enfermedad renal cronica.

Info

Publication number
MX2019001257A
MX2019001257A MX2019001257A MX2019001257A MX2019001257A MX 2019001257 A MX2019001257 A MX 2019001257A MX 2019001257 A MX2019001257 A MX 2019001257A MX 2019001257 A MX2019001257 A MX 2019001257A MX 2019001257 A MX2019001257 A MX 2019001257A
Authority
MX
Mexico
Prior art keywords
treatment
kidney disease
chronic kidney
renal cells
bioactive renal
Prior art date
Application number
MX2019001257A
Other languages
English (en)
Inventor
Jain Deepak
A Bertram Timothy
Original Assignee
Jain Deepak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jain Deepak filed Critical Jain Deepak
Publication of MX2019001257A publication Critical patent/MX2019001257A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a métodos para usar poblaciones de células renales bioactivas para proporcionar efectos regenerativos a un riñón nativo para el tratamiento de enfermedad renal crónica.
MX2019001257A 2016-07-29 2016-07-29 Celulas renales bioactivas para el tratamiento de enfermedad renal cronica. MX2019001257A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/044866 WO2018022108A1 (en) 2016-07-29 2016-07-29 Bioactive renal cells for the treatment of chronic kidney disease

Publications (1)

Publication Number Publication Date
MX2019001257A true MX2019001257A (es) 2019-10-02

Family

ID=56618275

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019001257A MX2019001257A (es) 2016-07-29 2016-07-29 Celulas renales bioactivas para el tratamiento de enfermedad renal cronica.

Country Status (11)

Country Link
US (1) US20210283182A1 (es)
EP (1) EP3490570A1 (es)
JP (1) JP2019527732A (es)
KR (1) KR20190065245A (es)
CN (1) CN109890397A (es)
AU (2) AU2016417160A1 (es)
BR (2) BR112019001409B1 (es)
CA (1) CA3031320A1 (es)
MX (1) MX2019001257A (es)
RU (1) RU2019105592A (es)
WO (1) WO2018022108A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
CN111033637B (zh) 2017-08-08 2023-12-05 费森尤斯医疗保健控股公司 用于治疗和评估慢性肾脏疾病的进程的系统和方法
AU2019333048A1 (en) * 2018-08-31 2021-03-11 Prokidney Compositions comprising cell-derived vesicles and uses thereof
AU2020266168A1 (en) * 2019-05-02 2021-12-02 Prokidney Treatment of kidney disease in subjects with kidney and/or urinary tract anomalies
KR102390458B1 (ko) * 2020-04-21 2022-04-26 이화여자대학교 산학협력단 요로 감염증의 재발 위험도 평가 방법
KR20230037721A (ko) 2021-09-09 2023-03-17 현대자동차주식회사 표면 평활성 및 표면품질이 우수한 열경화성 복합 수지 조성물 및 이를 이용한 성형물의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2358375B1 (en) * 2008-11-12 2013-07-24 Tengion, Inc. Isolated renal cells and uses thereof
CA3065694A1 (en) * 2010-11-10 2012-05-18 Inregen Methods of forming injectable formulations for providing regenerative effects to an organ such as a kidney
CN110184232B (zh) * 2012-10-24 2023-10-20 普罗基德尼 肾细胞群及其用途

Also Published As

Publication number Publication date
KR20190065245A (ko) 2019-06-11
US20210283182A1 (en) 2021-09-16
BR122019015270B1 (pt) 2022-03-03
BR112019001409B1 (pt) 2022-03-03
JP2019527732A (ja) 2019-10-03
BR112019001409A2 (pt) 2019-05-07
CN109890397A (zh) 2019-06-14
CA3031320A1 (en) 2018-02-01
RU2019105592A (ru) 2020-08-28
EP3490570A1 (en) 2019-06-05
AU2023203923A1 (en) 2023-08-31
RU2019105592A3 (es) 2020-08-28
WO2018022108A1 (en) 2018-02-01
AU2016417160A1 (en) 2019-03-07

Similar Documents

Publication Publication Date Title
MX2019001257A (es) Celulas renales bioactivas para el tratamiento de enfermedad renal cronica.
HK1255161A1 (zh) 用於過繼性細胞治療的工程細胞
EP4324473A3 (en) Multiparametric nucleic acid optimization
EA201990293A1 (ru) Мультиспецифичные антитела против cd40 и cd137
MX2016014248A (es) Compuestos polifluorados que actuan como inhibidores de la tirosina cinasa de bruton.
MY195167A (en) Modified Nucleotide Linkers
UY34503A (es) ?sal de bromhidrato de pridopidina?
MX2017007941A (es) Anticuerpos antagonistas anti-axl.
EA201400178A1 (ru) Лечение рака молочной железы
MX2016016886A (es) Anticuerpos anti-axl.
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
MY181994A (en) Immuno-modulatory progenitor (imp) cell
EA201790505A1 (ru) Соединение, нацеленое на ил-23а и фно-альфа, и его применение
EP3641811A4 (en) IMMUNPRIVILEGATED BIOACTIVE KIDNEY CELLS FOR TREATMENT OF KIDNEY DISEASE
MX2015013066A (es) Usos terapéuticos para anticuerpos contra vegfr1.
SG10201804034QA (en) Methods for treating hypotension
PH12016502150A1 (en) Method for treating renal cell carcimona
EA201790360A1 (ru) Получение полностью процессированного и функционального фактора x в фурин-секретирующей системе экспрессии млекопитающего
EA201691130A1 (ru) Средства и способы противодействия миелопролиферативным или лимфопролиферативным расстройствам
MX2023004126A (es) Celulas renales bioactivas para el tratamiento de enfermedad renal cronica.
EP3274050A4 (en) Myeloid progenitor cells in kidney disease
EP3936188C0 (en) CELLS FOR REGENERATIVE THERAPY
EA201891996A1 (ru) Лечение пациентов, перенесших трансплантацию гематопоэтических стволовых клеток
GR1008554B (el) Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
PH12018500339A1 (en) Lysobactin for use in the treatment of bovine mastitis